Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Taking finasteride every other month can still help with hair loss but may be less effective over time compared to taking it daily.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

Ketoconazole shampoo may help reduce hair loss and improve hair health.

Nanocarriers can make acne treatments more effective and gentle on the skin.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New treatments for hair loss show promise with advanced therapies and better targeting.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Testosterone may influence COVID-19 severity and outcomes.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Severe hair loss may increase the risk of dying from COVID-19.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.